Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: A report of the Pediatric Oncology Group and the Children's Cancer Group

American Journal of Obstetrics and Gynecology

Volumn 181, Issue 2, 1999, Pages 353-358

  Cushing, Barbara ^a,n   Giller, Roger ^b   Ablin, Arthur ^d   Cohen, Lewis ^e   Cullen, John ^c   Hawkins, Edith ^f   Heifetz, Stephen A ^g   Krailo, Mark ^h   Lauer, Stephen J ⁱ   Marina, Neyssa ^j   Rao, P V ^k   Rescorla, Frederick ^g   Vinocur, Charles D ^l   Weetman, Robert M ^g   Castleberry, Robert P ^m  

^a CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^b CHILDREN S HOSPITAL   (United States)

^c PRESBYTERIAN ST LUKE S MEDICAL CENTER   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Maine Children's Cancer Program Portland   (United States)

^f BAYLOR COLLEGE OF MEDICINE   (United States)

^g INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h Children's Cancer Grp Operations O   (United States)

ⁱ EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^j ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^k UNIVERSITY OF FLORIDA   (United States)

^l ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^m UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁿ Pediat Oncol Grp Operations Off   (United States)

more..

Author keywords

Gliomatosis peritonei; Immature teratoma; Ovary; Yolk sac tumor foci

Indexed keywords

ADOLESCENT; CANCER GRADING; CANCER RECURRENCE; CANCER SURGERY; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; FEMALE; GLIOSIS; HUMAN; INFANT; OVARY; OVARY TERATOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT OUTCOME; YOLK SAC TUMOR;

EID: 0032870767     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9378(99)70561-2     Document Type: Conference Paper

References (14)

1. 1. Gobel U, Calaminus G, Teske C, Baumberg M, Bokkerink JP, Haas RJ, et al. BEP/VIP in children and adolescents with malignant nontesticular germ cell tumors: a comparison of the results of treatment of therapy studies MAKEI 83/86 and 89P/89. Klin Padiatr 1993;205:231-40.
2. 2. Baranzelli MC, Flamant F, DeLumley L, LeGall E, Lejars O. Treatment of non-metastatic, non-seminomatous malignant germ-cell tumours in childhood: experience of the "Societe Francaise d'Oncologic Pediatrique" MGCT 1985-1989 study. Med Pediatr Oncol 1993;21:395-401.
3. 3. Gershenson DM, Del Junco G, Silva E, Copeland L, Wharton JT, Rutledge FN. Immature teratoma of the ovary. Obstet Gynecol 1986;68:624-9.
4. 4. Vergote IB, Abeler VM, Kjorstad KE, Trope C. Management of malignant ovarian immature teratoma: role of Adriamycin. Cancer 1990;66:882-6.
5. 5. Kawai M, Kano T, Yoshihito F, Iwata M, Nakashima N, Imai N, et al. Immature teratoma of the ovary. Gynecol Oncol 1991;40:133-7.
6. 6. Norris HJ, Zirkin HJ, Benson WL. Immature (malignant) teratoma of the ovary: a clinical and pathologic study of 58 cases. Cancer 1976;37:2359-72.
7. 7. Koulos JP, Hoffamn JS, Steinhoff MM. Immature teratoma of the ovary. Gynecol Oncol 1989;34:46-9.
8. 8. Bonnazzi G, Peccatori F, Colombo N, Lucchini V, Cantu MG, Mangioni C. Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients. Obstet Gynecol 1994;84:598-604.
9. 9. Robboy S J, Scully RE. Ovarian teratoma with glial implants on the peritoneum. Hum Pathol 1970;1:643-53.
10. 10. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
11. 11. Kalbfleisch JD, Prentice RL. Statistical analysis of failure time data. New York: John Wiley; 1980.
12. 12. O'Connor DM, Norris HJ. The influence of grade on outcome of stage 1 ovarian immature (malignant) teratomas and the reproducibility of grading. Int J Gynecol Pathol 1994;13:283-9.
13. 13. Williams SD, Blessing JA, Moore DH, Homesley HD, Adcock L. Cisplatin, vinblastine, and bleomycin in advanced and recurrent ovarian germ cell tumors: a trial of the Gynecologic Oncology Group. Ann Intern Med 1989;111:22-7.
14. 14. Dark GG, Bower M, Newlands ES, Paradinas F, Rustin GJ. Surveillance policy for stage 1 ovarian germ cell tumors. J Clin Oncol 1997;15:620-4.